SMITHS FALLS, ON, March 2, 2016 /CNW/ - Tweed Inc., a subsidiary of Canopy Growth Corporation (TSXV: CGC), wishes to issue a clarifying release. A recent press release issued by a company called "Quantum 9" indicates that Tweed endorses its services. In fact, no member of the Tweed's management team knows who Quantum 9 is.
In late 2013 a Tweed employee held a brief meeting with Quantum 9. Some years later, that individual penned a personal recommendation letter.
Tweed is proud of its accomplishments and the reputation it has built as a leader in the cannabis sector. And we have had the privilege of teaming up with real world-class leaders as we build something special.
Tweed has partnered with DNA Genetics, an award-winning powerhouse of genetics and breeding in the cannabis sphere. We teamed up with the Canadian AIDS Society to bring education initiatives to patients seeking answers, and DSG Inc. to build the backbone of the EQUAL clinical study. We have worked closely with Indoor Harvest to explore groundbreaking aeroponics technology. We have incredible research partners at leading Canadian universities, and most recently we partnered with cannabis icon Snoop Dogg.
Quantum 9 does not fit into that category and we do not endorse or recommend their services.
About Tweed Inc
Tweed Inc. is a Canadian company licensed under the Marihuana for Medical Purposes Regulations to produce and sell marijuana to authorized customers. Tweed strives to supply a wide selection of marijuana, as diverse as the patients who trust the company with their patronage. For more information visit www.tweed.com
About Canopy Growth Corporation
Canopy is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with dual licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed Inc., Tweed Farms Inc., and Bedrocan Cannabis Corp., the Company operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions.
The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, and furthering the public's understanding of how marijuana is used for medical purposes. For more information visit www.canopygrowth.com
Forward Looking Statement
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, Tweed Inc., Tweed Farms Inc. or Bedrocan Canada Inc. to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Here's to Future Growth.
SOURCE Canopy Growth Corporation
For further information: Media Contact: Jordan Sinclair, [email protected], 855-558-9333 ex 309; Investor Contact: Tyler Burns, [email protected], 855-558-9333 ex 122; Director: Bruce Linton, [email protected]